Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EnQuest removes Heather Alpha topsides in huge lift operation

(Sharecast News) - EnQuest announced the completion of the safe removal of the Heather Alpha topsides on Thurdsay, marking a major milestone in its North Sea decommissioning programme. The London-listed company said the 15,300-tonne structure was lifted in a single operation on 11 August by the Allseas-owned Pioneering Spirit, the largest planned single lift in the North Sea this year.

It said the removal followed three years of planning, engineering and offshore preparation by EnQuest's in-house decommissioning team in collaboration with Allseas and other specialist contractors.

The topsides were being transported to Frederikshavn in Denmark for dismantling, with over 95% of the structure expected to be recycled and repurposed to minimise the project's carbon footprint.

"The removal of the Heather Alpha topsides is a tremendous accomplishment for the EnQuest team, as well as our colleagues at Allseas and across the project support network," said EnQuest decommissioning director John Allan.

"The Pioneering Spirit completed the lift in around 14 seconds, but that astonishing reality was only made possible by three years of meticulous planning, engineering and preparation works.

"After almost 50 years of operations in the North Sea, Heather Alpha's legacy is to be an exemplar of a best-in-class decommissioning project, from inception to the responsible recycling of its materials."

At 1039 BST, shares in EnQuest were down 0.83% at 12.57p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.